A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 1, 2003, Pages 68-70

  Johne, Andreas ^a   Roots, Ivar ^a   Brockmöller, Jürgen ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; DNA ISOLATION; DNA POLYMORPHISM; EXON; FEMALE; GENE SEQUENCE; GENETIC RISK; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER NEOPLASMS;

EID: 0037243444     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
2. Lowy, D. R., and Willumsen, B. M. Function and regulation of ras. Annu. Rev. Biochem., 62: 851-891, 1993.
3. Bos, J. L. ras oncogenes in human cancer: a review, Cancer Res., 49: 4682-4689, 1989.
4. Czerniak, B., Cohen, G. L., Etkind, P., Deitch, D., Simmons, H., Herz, F., and Koss, L. G. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas, Hum. Pathol., 23: 1199-1204, 1992.
5. Knowles, M. A., and Williamson, M. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis. designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res., 53: 133-139, 1993.
6. Levesque, P., Ramchurren, N., Saini, K., Joyce, A., Libertino, J., and Summerhayes, I. C. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. Int. J. Cancer, 55: 785-790, 1993.
7. Burchill, S. A., Neal, D. E., and Lunec, J, Frequency of H-ras mutations in human bladder cancer detected by direct sequencing. Br. J. Urol., 73: 516-521, 1994.
8. Olderoy, G., Daehlin, L., and Ogreid, D. Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder. Anticancer Res., 18: 2675-2678, 1998.
9. Rabbani, F., and Cordon-Cardo, C. Mutation of cell cycle regulators and their impact on superficial bladder cancer. Urol. Clin. North Am., 27: 83-102, 2000.
10. Taparowsky, E., Suard, Y., Fasano, O., Shimizu, K., Goldfarb, M., and Wiggler, M. Activation of the 724 bladder carcinoma transforming gene is linked to a single amino acid change. Nature (Lond.), 300: 762-765, 1982.
11. Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H., and Goeddel, D. V. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature (Lond.), 302. 33-37, 1983.
12. Reddy, E. P. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science (Wash. DC), 220: 1061-1063, 1983.
13. Krontiris, T. G., Devlin, B., Karp. D. D., Robert, N. J., and Risch, N. An association between the risk of cancer and mutations in the HRASI minisatellite locus. N. Engl. J. Med., 329: 517-523. 1993.
14. Brockmöller, J., Casuorbi, I., Kerb, R., and Roots, I. Conbined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, micmsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk, Cancer Res., 56: 3915-3925, 1996.
15. McGrath, J. P., Capon, D. J., Smith. D. H., Chen, E. Y., Seeburg, P. H., Goeddel, D, V., and Levinson, A. D. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (Lond.), 304: 501-506, 1983.
16. Taparowsky, E., Shimizu, K., Goldfarb, M., and Wigler, M. Structure and activation of the human N-ras gene. Cell, 34: 581-586, 1983.
17. Sekiya, T., Fushimi, M., Hori, H., Hirohashi, S., Nishimura, S., and Sugimura, T. Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. Proc. Natl. Acad. Sci. USA, 81: 4771-4775, 1984.
18. Mantel, N., and Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. (Bethesda), 22: 719-748, 1959.
19. Brockmöller, J., Kaiser, R., Kerb, R., Cascorbi, I., Jaeger, V., and Roots, I. Polymorphic enzymes of xenobiotic metabolism as modulators of acquired p53 mutations in bladder cancer. Pharmacogenetics, 6: 535-545, 1996.
20. Cattan. N., Saison-Behmoaras, T., Mari, B., Mazeau, C., Amiel, J. L., Rossi, B., and Gioanni, J. Screening of human bladder carcinomas for the presence of Ha-ras codon 12 mutation. Oncol. Rep., 7: 497-500. 2000.
21. Spruck, C. H. III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., Cote, R., et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784-788, 1994.
22. Green, M., and Krontiris, T. G. Allelic variation of reporter gene activation by the HRASI minisatellite. Genomics. 17: 429-434, 1993.
23. Kotsinas, A., Gorgoulis, V. G., Zacharatos, P., Mariatos, G., Kokotas, S., Liloglou, T., Ikonomopoulos, J., Zoumpourlis, V., Kyroudi, A., Field, J. K., Asimacopoulos, P. J., and Kittas, C. Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas. Cancer Genet. Cytogenet., 126: 147-154, 2001.